Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |